Loading company…
RapidPulse develops minimally invasive vascular devices for treating ischemic stroke.
RapidPulse is a medical device company and a spinout of Syntheon LLC. It develops the Cyclic Aspiration System, which uses an aspiration pump to remove blood clots from the brain. In July 2026, it raised USD 48 million in Series B funding co-led by Medtronic, TechWald Holding, and S3 Ventures, with participation from SBI Investment, Florida Opportunity Fund, Sante Ventures, Syntheon LLC, Hatteras Venture Partners, and Epidarex Capital. CEO Sean McBrayer leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in